Description
Evidence Tier · Randomized Controlled Trials
Vitamin C, vitamin E, zinc and copper based on the National Eye Institute AREDS formula, with bilberry and lutein.
What It Does
Supports healthy vision and eye function as you age.*
How It Works
The retina has high oxygen use and light exposure. Antioxidant vitamins and zinc protect retinal cells from oxidative stress.
Why This Form
Vitamin C at 500 mg and zinc at 80 mg match the AREDS formula. Copper is included because high-dose zinc can lower copper.
Clinical Evidence
The Age-Related Eye Disease Study, a randomized trial sponsored by the National Eye Institute, tested antioxidants and zinc over a mean of 6.3 years.¹ AREDS2 tested adding lutein and zeaxanthin.²
What The Evidence Does Not Show
AREDS studied people with existing eye conditions and is cited for formulation basis only. Vitamin E and lutein here are lower than in AREDS and AREDS2. 80 mg zinc is above the upper limit for long-term use without medical guidance.
Supplement Facts
| Per Serving | Amount | % DV |
|---|---|---|
| Vitamin C (as ascorbic acid) | 500 mg | 560% |
| Vitamin E | 30 mg | 200% |
| Zinc (as zinc citrate) | 80 mg | 730% |
| Copper (as copper gluconate) | 0.9 mg | 100% |
| Bilberry powder (fruit) | 200 mg | † |
| Eyebright extract 10:1 | 10 mg | † |
| Lutein 5% (marigold flower) | 2 mg | † |
† Daily Value not established.
Other Ingredients
Capsule. Full panel on the label.
Warnings
Contains 80 mg zinc. Use long term only under medical guidance. Consult your physician if pregnant, nursing, or taking medication. Keep out of reach of children. Do not use if the safety seal is damaged or missing. Store in a cool, dry place.
References
- Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436. National Eye Institute. PubMed 11594942
- Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA. 2013;309(19):2005-2015. National Eye Institute. PubMed 23644932
Institution names identify where the cited research was conducted. University Vitamins is not affiliated with or endorsed by these institutions. Our Research Standard →
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.